A study funded by a Canadian biopharmaceutical company estimates that the combined health-care and productivity costs to Canada from verotoxigenic E. coli-related (VTEC) infections total about $404 million per year. The peer-reviewed study, to be published in the Journal of Food Protection, indicates that 93 percent of VTEC infections are
Continue Reading Study: E. Coli Infections Cost Canada $400 Million Annually
Cargill Field Tests E. coli Vaccine
A dozen or so feedlots around the Fort Morgan, CO beef plant owned by Cargill Meat Solutions have been enlisted in a field trial for a vaccine against E. coli O157:H7.
The plan, according to Cargill’s Mark Klein, is to give the vaccine to about 100,000 cattle that will be
Field Tests Planned for E. coli Vaccines
Whether new vaccines against E. coli O157:H7 can work well enough to be economically viable could be decided by new large field trials that are just getting underway.
Two vaccines are in trial. Willmar, MN-based Epitopix gained approval about ten months ago for sales of its vaccine against E. coli